Cimpean Anca Maria, Tamma Roberto, Ruggieri Simona, Nico Beatrice, Toma Alina, Ribatti Domenico
Department of Microscopic Morphology/Histology, Angiogenesis Research Center, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania.
Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy,; National Cancer Institute "Giovanni Paolo II", Bari, Italy.
Crit Rev Oncol Hematol. 2017 Jul;115:23-26. doi: 10.1016/j.critrevonc.2017.04.009. Epub 2017 Apr 27.
Mast cells, accumulate in the stroma surrounding certain tumors and take part to the inflammatory reaction occurring at the periphery of the tumor. Mast cell-secreted angiogenic cytokines facilitate tumor vascularization not only by a direct effect but also by stimulating other inflammatory cells of the tumor microenvironment to release other angiogenic mediators. An increased number of mast cells have been demonstrated in angiogenesis associated with solid tumors, including breast cancer. Mast cells might act as a new target for the adjuvant treatment of breast cancer through the selective inhibition of angiogenesis, tissue remodeling and tumor promoting molecules, allowing the secretion of cytotoxic cytokines and preventing mast cell mediated immune-suppression.
肥大细胞积聚在某些肿瘤周围的基质中,并参与肿瘤周边发生的炎症反应。肥大细胞分泌的血管生成细胞因子不仅通过直接作用促进肿瘤血管生成,还通过刺激肿瘤微环境中的其他炎症细胞释放其他血管生成介质来实现。在包括乳腺癌在内的实体瘤相关血管生成中,已证实肥大细胞数量增加。肥大细胞可能通过选择性抑制血管生成、组织重塑和肿瘤促进分子,允许细胞毒性细胞因子的分泌并防止肥大细胞介导的免疫抑制,从而成为乳腺癌辅助治疗的新靶点。